REGENERON PHARMACEUTICALS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 893.2 USD | +1.13% |
|
-0.77% | +1.70% |
| 04-26 | Regeneron Faces Q1 Seasonality Despite Eylea HD Launch, Oppenheimer Says | MT |
| 04-26 | Oppenheimer Adjusts Price Target on Regeneron Pharmaceuticals to $1,175 From $1,125 | MT |
Official Publications
| SEC Filing 10K | CO | |
| SEC Filing 8K | CO | |
| Slide show results | CO | |
| Annual results | CO | |
| SEC Filing 8K | CO | |
| SEC Filing 8K | CO | |
| 3rd quarter results | CO | |
| SEC Filing 10Q-3 | CO | |
| Slide show Q3 | CO | |
| Slide show half-year results | CO | |
| 1st-half-year results | CO | |
| SEC Filing 10Q-2 | CO | |
| SEC Filing 8K | CO | |
| Slide show Q1 | CO | |
| SEC Filing 10Q-1 | CO | |
| 1st quarter results | CO | |
| Proxy Statments | CO | |
| Annual ESG Report | CO | |
| SEC Filing 10K | CO | |
| SEC Filing 8K | CO | |
| Slide show results | CO | |
| Annual results | CO | |
| SEC Filing 13G | CO | |
| 3rd quarter results | CO | |
| Slide show Q3 | CO |
- Stock Market
- Equities
- REGN Stock
- News Regeneron Pharmaceuticals, Inc.
- Official Publications
